Previous 10 |
home / stock / vphif / vphif news
Valeo Pharma (VPHIF): FQ3 net loss of $1.6MRevenue of $1.5M (-42.3% Y/Y)Press Release For further details see: Valeo Pharma reports FQ3 results
Valeo Pharma Reports its Third Quarter 2020 Results and Highlights Canada NewsWire MONTREAL, Sept. 29, 2020 $6.9 million bought deal offering with full exercice of over-allotment option $1.7 million oversubscribed non-convertible debenture non...
News, Short Squeeze, Breakout and More Instantly...
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE Canada NewsWire MONTREAL , June 18, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical compan...
(NewsDirect) Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the second quarter, which saw record-breaking revenue for the period. The company reported revenues of $14.1 million for Q2, an increase from the $13.6 million rec...
VALEO PHARMA ANNOUNCES RESTRUCTURING OF COMMERCIAL FIELD OPERATIONS TO SUPPORT PATH TO PROFITABILITY Canada NewsWire Changes to respiratory business unit to generate more than $5 million in annual savings Follows previously announced cost saving measures exce...